VP
venBio Partners Portfolio holdings
AUM
$115M
This Quarter Return
-23.6%
1 Year Return
-33.99%
3 Year Return
+221.07%
5 Year Return
+224.54%
10 Year Return
–
AUM
$232M
AUM Growth
+$232M
(-18%)
Cap. Flow
+$36.9M
Cap. Flow
% of AUM
15.93%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$37.6M |
Top Sells
| 1 |
ELEV
Elevation Oncology
ELEV
|
$707K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.39B
| $80.6M | 34.83% | 4,289,304 | – | – |
|
2
ALX Oncology
ALXO
$62.7M
| $58.5M | 25.26% | 9,699,925 | – | – |
|
|
ALMS
3
Alumis Inc. Common Stock
ALMS
$479M
| $37.6M | 16.23% | +2,826,048 | New | +$37.6M |
|
4
Harmony Biosciences
HRMY
$2.12B
| $31.2M | 13.49% | 1,035,396 | – | – |
|
|
SLRN
5
DELISTED
ACELYRIN
SLRN
| $17M | 7.34% | 3,852,470 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $6.57M | 2.84% | 2,434,255 -261,878 | -10% | -$707K |
|